28 results on '"Nazareth, Tara"'
Search Results
2. Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population
3. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey
4. 33356 A multinational chart review to examine gastrointestinal symptoms and their management in patients treated with apremilast for plaque psoriasis
5. Real-world health outcomes in US adult patients with mild to moderate plaque psoriasis taking topical therapy
6. 26603 Real-world health outcomes in US adult patients with mild-to-moderate plaque psoriasis taking topical therapy: Results from a chart review
7. Comparability of European League Against Rheumatology-Recommended Pharmacological Treatments of Oral Ulcers Associated with Behçet’s Disease: A Systematic Literature Review of Randomized Controlled Trials
8. Medication Utilization Patterns 90 Days Before Initiation of Treatment with Repository Corticotropin Injection in Patients with Infantile Spasms
9. Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of U.S. Claims Data
10. Incidence of Elevated Liver Enzymes in Rheumatoid Arthritis Patients: 587.
11. Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials
12. SAT0574 A SYSTEMATIC LITERATURE REVIEW OF HEALTHCARE BURDEN IN PATIENTS WITH BEHÇET’S DISEASE
13. MS Relapse Treatments and Relapse Resolution: Retrospective Study Results from a US Health Plan
14. Relapse Resolution and HCRU in Patients with Multiple Sclerosis: A Retrospective Study of Relapse Therapy Alternatives to Corticosteroids
15. Outcomes-Based Contracting Experience: Research Findings from U.S. and European Stakeholders
16. Medical Resource Utilization in Patients with Infantile Spasms After Receipt of Repository Corticotropin Injection (H.P. Acthar Gel): Results of a Physician Survey (P3.219)
17. The Economic Burden of Moderate-to-Severe Multiple Sclerosis Relapse in the United States: Findings from a Systematic Literature Review (P3.402)
18. Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review
19. Real World Relapse Rates of Glatiramer Acetate Patients Switching to Fingolimod or Interferon Beta-1a Versus Remaining on Glatiramer Acetate (P6.181)
20. Burden of illness among patients with fragile X syndrome (FXS): a Medicaid perspective
21. Physician-Patient Concordance in Pharmacological Management of Patients with COPD
22. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America2017 survey
23. Cost-effectiveness (CE) of fingolimod vs. intramuscular interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis (RRMS) (P1.137)
24. Comparison of Relapse Rates in Multiple Sclerosis Patients Switching from Glatiramer Acetate to Fingolimod versus Those Remaining on Glatiramer Acetate (P3.254)
25. Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia
26. Burden of illness among patients with fragile X syndrome (FXS): a Medicaid perspective.
27. Hyperlipidemia Guideline Adherence and Association with Patient Gender
28. Medication Utilization Patterns 90 Days Before Initiation of Treatment with Repository Corticotropin Injection in Patients with Infantile Spasms.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.